Bradley is pleased to announce that partners Leigh Anne Hodge, Lela M. Hollabaugh and Kimberly B. Martin have been named to Benchmark Litigation’s Top 250 Women in Litigation list for 2022.
“We are proud of Leigh Anne, Lela and Kim and congratulate them on their continued recognition as top female litigators,” said Bradley Chairman of the Board and Managing Partner Jonathan M. Skeeters. “Their inclusion on this prestigious list is well deserved.”
The annual Top 250 Women in Litigation list, published by Benchmark Litigation, highlights some of the most distinguished women in litigation and is based on a culmination of research and client feedback.
Ms. Hodge leads Bradley’s Litigation Practice Group and is based in the firm’s Birmingham office. She is also a member of the Healthcare Practice Group, representing clients in the healthcare industry in regional and national engagements. Ms. Hodge provides counsel regarding product liability litigation, medical malpractice litigation, peer review and staff privileges matters, administrative hearings before licensure boards, ERISA litigation, Medicare Advantage plan litigation, managed care litigation, insurance disputes and insurance fraud cases.
Ms. Hollabaugh is based in the firm’s Nashville office and has served as the lead trial lawyer in more than a dozen jury trials, as well as more than two dozen bench trials, arbitrations and administrative hearings. She advises leading natural gas pipeline companies and other infrastructure clients on issues involving location, land acquisition, construction and operations. Ms. Hollabaugh has co-authored an amicus curiae brief to the U.S. Supreme Court in support of the industry’s position in the scope of the Natural Gas Act and the state’s 11th Amendment immunity.
Ms. Martin is based in Bradley’s Huntsville office and focuses on general litigation with an emphasis on medical device and pharmaceutical products liability litigation, as well as white collar matters and False Claims Act litigation. Ms. Martin has represented multi-national pharmaceutical and medical device manufacturers in litigation matters across the country.
Original source can be found here.